Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1984 1
1986 2
1987 3
1988 3
1989 2
1990 2
1991 4
1992 1
1993 4
1994 1
1995 4
1996 3
1997 2
1998 3
1999 3
2000 3
2001 1
2002 3
2003 1
2004 1
2005 3
2006 1
2007 2
2008 2
2009 1
2010 2
2011 6
2012 2
2013 2
2014 1
2015 3
2016 2
2017 5
2018 4
2019 8
2020 4
2021 3
2022 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
Yeh R, O'Donoghue JA, Jayaprakasam VS, Mauguen A, Min R, Park S, Brockway JP, Bromberg JF, Zhi WI, Robson ME, Sanford R, Modi S, Agnew BJ, Lyashchenko SK, Lewis JS, Ulaner GA, Zeglis BM. Yeh R, et al. Among authors: o donoghue ja. J Nucl Med. 2024 Mar 1;65(3):386-393. doi: 10.2967/jnumed.123.266392. J Nucl Med. 2024. PMID: 38272704 Free PMC article.
Theranostics: The Role of Quantitative Nuclear Medicine Imaging.
Könik A, O'Donoghue JA, Wahl RL, Graham MM, Van den Abbeele AD. Könik A, et al. Among authors: o donoghue ja. Semin Radiat Oncol. 2021 Jan;31(1):28-36. doi: 10.1016/j.semradonc.2020.07.003. Semin Radiat Oncol. 2021. PMID: 33246633 Review.
The radiobiology of targeted radiotherapy.
Wheldon TE, O'Donoghue JA. Wheldon TE, et al. Among authors: o donoghue ja. Int J Radiat Biol. 1990 Jul;58(1):1-21. doi: 10.1080/09553009014551401. Int J Radiat Biol. 1990. PMID: 1973428 Review.
Lesion Dosimetry for [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
Grkovski M, O'Donoghue JA, Imber BS, Andl G, Tu C, Lafontaine D, Schwartz J, Thor M, Zelefsky MJ, Humm JL, Bodei L. Grkovski M, et al. Among authors: o donoghue ja. J Nucl Med. 2023 Nov;64(11):1779-1787. doi: 10.2967/jnumed.123.265763. Epub 2023 Aug 31. J Nucl Med. 2023. PMID: 37652541 Free PMC article.
Hypoxia in microscopic tumors.
Li XF, O'Donoghue JA. Li XF, et al. Among authors: o donoghue ja. Cancer Lett. 2008 Jun 18;264(2):172-80. doi: 10.1016/j.canlet.2008.02.037. Epub 2008 Apr 1. Cancer Lett. 2008. PMID: 18384940 Free PMC article. Review.
[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Krebs S, Grommes C, McDevitt MR, Carlin SD, O'Donoghue JA, Graham MS, Young RJ, Schöder H, Gutin PH, Bander NH, Osborne JR. Krebs S, et al. Among authors: o donoghue ja. Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):783-785. doi: 10.1007/s00259-021-05543-5. Epub 2021 Sep 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 34498111 No abstract available.
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer.
Pandit-Taskar N, O'Donoghue JA, Chetty D, Max S, Wanik D, Ilovich O, Russell M, Nyima T, Divgi CR, Yu M, Morris MJ. Pandit-Taskar N, et al. Among authors: o donoghue ja. J Nucl Med. 2024 Jul 1;65(7):1051-1056. doi: 10.2967/jnumed.124.267416. J Nucl Med. 2024. PMID: 38782459 Free PMC article.
Bone marrow dosimetry using 124I-PET.
Schwartz J, Humm JL, Divgi CR, Larson SM, O'Donoghue JA. Schwartz J, et al. Among authors: o donoghue ja. J Nucl Med. 2012 Apr;53(4):615-21. doi: 10.2967/jnumed.111.096453. Epub 2012 Mar 13. J Nucl Med. 2012. PMID: 22414633 Free PMC article.
98 results